New hope for tough cancers: first human test of experimental drug begins
NCT ID NCT06723236
Summary
This is the first study in humans of an experimental drug called MGC028 for people with advanced solid tumors that have stopped responding to standard treatments. Researchers will test increasing doses in about 124 participants to find the highest safe amount and check for side effects. They will also see if the drug can shrink tumors or stop cancer from growing in people with specific cancers like lung, pancreatic, bile duct, or colorectal cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dana Farber/Harvard Cancer Center
RECRUITINGBoston, Massachusetts, 02115, United States
Contact
-
Icahn School of Medicine at Mt. Sinai
RECRUITINGNew York, New York, 10029, United States
Contact
-
South Texas Accelerated Research Therapeutics (START) Midwest
RECRUITINGGrand Rapids, Michigan, 49546, United States
Contact
-
South Texas Accelerated Research Therapeutics (START) Mountain Region
RECRUITINGWest Valley City, Utah, 84119, United States
Contact
-
South Texas Accelerated Research Therapeutics (START) San Antonio
RECRUITINGSan Antonio, Texas, 78229, United States
Contact
-
UCSF - Helen Diller Family Cancer Center
RECRUITINGSan Francisco, California, 94115, United States
Contact
Conditions
Explore the condition pages connected to this study.